HIGHLIGHTS
- who: Tao Li and colleagues from the IRCCS, Italy University, China have published the paper: Effectiveness and safety of anti-PD-1 monotherapy or combination therapy in Chinese advanced gastric cancer: A real-world study, in the Journal: (JOURNAL) of May/31,/2015
- what: The study evaluated the effectiveness and safety anti-PD-1-based treatment (monotherapy or combination in patients with or metastatic GC/GEJCs in a real-world setting. Methods: A retrospective cohort study was conducted and 54 patients from May 31 2015 to May 31 2021 were included in the analysis including . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.